Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review

Saved in:
Bibliographic Details
Published in:Clinical Ophthalmology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870840847349579776
collection WordPress RSS
FRELIP Feed Integration
container_title Clinical Ophthalmology
description
discipline_display Ophthalmology and Optometry
discipline_facet Ophthalmology and Optometry
format Online Article
RSS Article
genre Journal Article
id rss_article:103239
institution FRELIP
journal_source_facet Clinical Ophthalmology
last_indexed 2026-07-16T03:34:25.921Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
Ophthalmology and Optometry
General
Ophthalmology and Optometry
sub_discipline_display General
sub_discipline_facet General
subject_display Ophthalmology and Optometry
General
Ophthalmology and Optometry
subject_facet Ophthalmology and Optometry
General
Ophthalmology and Optometry
title Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
title_alt Ganancias visuales con faricimab frente a aflibercept 8 mg en enfermedad retinovascular virgen: Casos reales globales y revisión de la literatura
Gains visuels avec le faricimab vs l'aflibercept 8 mg dans les maladies rétinovaseulaires naïves : Cas réels mondiaux et revue de la littérature
Ganhos Visuais com Faricimabe vs Aflibercepte 8 mg em Doença Retinovascular Virgem de Tratamento: Casos Reais Globais e Revisão da Literatura
title_auth Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
title_es_txt Ganancias visuales con faricimab frente a aflibercept 8 mg en enfermedad retinovascular virgen: Casos reales globales y revisión de la literatura
title_fr_txt Gains visuels avec le faricimab vs l'aflibercept 8 mg dans les maladies rétinovaseulaires naïves : Cas réels mondiaux et revue de la littérature
title_full Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
title_fullStr Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
title_full_unstemmed Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
title_pt_txt Ganhos Visuais com Faricimabe vs Aflibercepte 8 mg em Doença Retinovascular Virgem de Tratamento: Casos Reais Globais e Revisão da Literatura
title_short Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
title_sort visual gains with faricimab vs aflibercept 8 mg in naïve retinovascular disease: global real-world cases and literature review
topic Ophthalmology and Optometry
General
Ophthalmology and Optometry
url https://www.dovepress.com/visual-gains-with-faricimab-vs-aflibercept-8-mg-in-nave-retinovascular-peer-reviewed-fulltext-article-OPTH